glp-1 gip and glucagon GLP1-GIP receptor co-agonists: a promising evolution in the treatment of type 2 diabetes | Acta Diabetologica Frontiers | Clinical perspectives on
Description
S.TickleT
Lixisenatide and twice-daily exenatide were compared in the GetGoal-X trial, which found that lixisenatide was not inferior to exenatide in lowering HbA1c ( 0.79% vs
The generic company which got the approval first, will benefit from 180-day exclusivity on the market before the other companies lauch theirs
Is this the same as Ozempic
GLP-1 plays a pivotal role in regulating blood sugar levels and appetite, making it an effective tool for sustainable weight management
